Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Autoimmune Disorders

Free Subscription 23.09.2019 2 Diabetes 1 J Clin Endocrinol Metab 1 J Neuroimmunol 2 J Neurol 2 Mult Scler 1 Nat Rev Neurol 1 PLoS Med 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Diabetes

1. VAN LUMMEL M, Buis DTP, Ringeling C, de Ru AH, et al
   Epitope Stealing as Mechanism of Dominant Protection by HLA-DQ6 in Type 1 Diabetes.
   Diabetes. 2019 Jan 9. pii: db18-0501. doi: 10.2337/db18-0501.
   PubMed     Text format    
   
   
2. SELVARAJAH D, Wilkinson ID, Fang F, Sankar A, et al
   Structural and Functional Abnormalities of the Primary Somatosensory Cortex in Diabetic Peripheral Neuropathy: A Multimodal MRI Study.
   Diabetes. 2019 Jan 7. pii: db18-0509. doi: 10.2337/db18-0509.
   PubMed     Text format     Abstract available
   
   

   
   J Clin Endocrinol Metab

3. RADERMACHER LK, Ponto KA, Merkesdal S, Pomart V, et al
   Type I Diabetes Is The Main Cost Driver In Autoimmune Polyendocrinopathy.
   J Clin Endocrinol Metab. 2019 Sep 16. pii: 5570009. doi: 10.1210.
   PubMed     Text format     Abstract available
   
   

   
   J Neuroimmunol

4. KURTUNCU M, Yilmaz V, Akcay HI, Turkoglu R, et al
   Impact of fingolimod on CD4+ T cell subset and cytokine profile of relapsing remitting multiple sclerosis patients.
   J Neuroimmunol. 2019;337:577065.
   PubMed     Text format     Abstract available
   
   

   
   J Neurol

5. PAOLICELLI D, Lucisano G, Manni A, Avolio C, et al
   Retrospectively acquired cohort study to evaluate the long-term impact of two different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis (RE.LO.DI.MS): data from the Italian MS Register.
   J Neurol. 2019 Sep 18. pii: 10.1007/s00415-019-09531.
   PubMed     Text format     Abstract available
   
   
6. GUGER M, Enzinger C, Leutmezer F, Kraus J, et al
   Correction to: Switching from natalizumab to fingolimod treatment in multiple sclerosis: real life data from the Austrian MS Treatment Registry.
   J Neurol. 2019 Sep 17. pii: 10.1007/s00415-019-09535.
   PubMed     Text format     Abstract available
   
   

   
   Mult Scler

7. MAGGI P, Absinta M, Sati P, Perrotta G, et al
   The "central vein sign" in patients with diagnostic "red flags" for multiple sclerosis: A prospective multicenter 3T study.
   Mult Scler. 2019 Sep 19:1352458519876031. doi: 10.1177/1352458519876031.
   PubMed     Text format     Abstract available
   
   
8. PALOTAI M, Guttmann CR
   Brain anatomical correlates of fatigue in multiple sclerosis.
   Mult Scler. 2019 Sep 19:1352458519876032. doi: 10.1177/1352458519876032.
   PubMed     Text format     Abstract available
   
   

   
   Nat Rev Neurol

9. DONG Y, Yong VW
   When encephalitogenic T cells collaborate with microglia in multiple sclerosis.
   Nat Rev Neurol. 2019 Sep 16. pii: 10.1038/s41582-019-0253.
   PubMed     Text format     Abstract available
   
   

   
   PLoS Med

10. ENG SWM, Aeschlimann FA, van Veenendaal M, Berard RA, et al
    Patterns of joint involvement in juvenile idiopathic arthritis and prediction of disease course: A prospective study with multilayer non-negative matrix factorization.
    PLoS Med. 2019;16:e1002750.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

11. OCANA GJ, Sims EK, Watkins RA, Ragg S, et al
    Analysis of serum Hsp90 as a potential biomarker of beta cell autoimmunity in type 1 diabetes.
    PLoS One. 2019;14:e0208456.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: